Innovation, sustainable development! Accompanied by fireworks, Nanjing Shuangwei Biomedical Technology Co., Ltd."R & D and industrialization project of blood riboflavin pathogen inactivation products"The development has officially entered a new stage.

August1On the 5th, "Nanjing Shuangwei Biomedical Technology Co., Ltd. Blood Riboflavin Pathogen Inactivation Product Research and Development and Industrialization Project Commencement Ceremony" was held in Jiangbei New District Biomedical Valley, Nanjing Shuangwei Biomedical Technology Co., Ltd.(hereinafter referred to"Sunway Creatures")Held smoothly.

The building area of the riboflavin workshop is about2500 square meters, built"C A" class GMP purification workshop.The whole project involves purification workshop construction, architectural decoration, water and electricity fire fighting and other professional fields. The total investment of the project is 50 million yuan, forming an annual output.Riboflavin Blood Pathogen Inactivation Equipment10 million setsthe abilityIt is expected that the riboflavin workshop will be completed and put into operation by the end of 2023.

Zhou Jun, general manager of Shuangwei Biology, said: The construction, acceptance and use of riboflavin workshop will accelerate the type inspection and clinical trials of riboflavin pathogen inactivation products, laying a solid foundation for the products to obtain registration certificates and smoothly go on the market to serve blood safety.

The completion of this project means that Sunway Biology, under the guidance of the China Medical Health Innovation Project, has developed a new type of blood pathogen inactivation product, filled the domestic gap with new technologies, further reduced the risk of pathogen transmission, and improved blood safety. At the same time, another milestone in building a safe blood transfusion base will have long-term significance for enhancing the international competitiveness of medical devices in the field of safe blood transfusion in my country.